@article{10840,
  keywords = {Humans, *Losartan/therapeutic use, Irbesartan/therapeutic use, Valsartan/therapeutic use, Angiotensin Receptor Antagonists/therapeutic use, Retrospective Studies, Cohort Studies, *Hypertension, Tetrazoles/therapeutic use, Biphenyl Compounds/therapeutic use, angiotensin-converting enzyme inhibitors, Canada, Denmark, United Kingdom, Cardiac Epidemiology, epidemiology, heart failure, hypertension},
  author = {E. Eworuke and M. Shinde and L. Hou and M. Paterson and P. Jensen and J. Maro and A. Rai and D. Scarnecchia and D. Pennap and D. Woronow and R. Ghosh and S. Welburn and A. Pottegard and R. Platt and H. Lee and M. Bradley},
  title = {Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study},
  year = {2023},
  journal = {BMJ Open},
  volume = {13},
  edition = {2023/04/18},
  number = {4},
  pages = {e070985},
  isbn = {2044-6055},
  doi = {10.1136/bmjopen-2022-070985},
  note = {2044-6055
Eworuke, Efe
Orcid: 0000-0001-8971-9748
Shinde, Mayura
Hou, Laura
Paterson, Michael J
Jensen, Peter Bjødstrup
Maro, Judith C
Rai, Ashish
Scarnecchia, Daniel
Orcid: 0000-0001-9486-4974
Pennap, Dinci
Woronow, Daniel
Ghosh, Rebecca E
Welburn, Stephen
Orcid: 0000-0001-5620-0536
Pottegard, Anton
Platt, Robert W
Lee, Hana
Bradley, Marie C
Orcid: 0000-0002-6266-4414
Journal Article
Research Support, Non-U.S. Gov't
England
BMJ Open. 2023 Apr 17;13(4):e070985. doi: 10.1136/bmjopen-2022-070985.},
  language = {eng},
}